Data / Research funding / Connecticut / Atlasxomics Inc.
Atlasxomics Inc.: 5 NIH awards ($3.1M), fiscal years 2021 to 2026
Atlasxomics Inc. in New Haven, CT is funded under 5 NIH awards ($3.1M) in the NIH and NSF award files, read 2026-11-04. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- LVJJTHPGMQJ9
- State
- Connecticut
Awards
5 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|
| A democratized platform for mapping the spatial epigenome in tissue | NIH | National Cancer Institute | 2023 to 2024 | $1,845,801 | September 19, 2023 | August 31, 2025 | SABINA, JEFFREY | reporter.nih.gov |
| Co-profiling (whole transcriptome and epigenome) of intact tissue to understand gene regulatory networks | NIH | National Human Genome Research Institute | 2024 | $400,000 | March 11, 2024 | February 28, 2025 | SABINA, JEFFREY | reporter.nih.gov |
| Development of a user-friendly next generation epigenomic chip adaptable to automation workflows | NIH | National Human Genome Research Institute | 2024 | $399,929 | July 1, 2024 | December 31, 2024 | MCCONNELL, TIMOTHY S | reporter.nih.gov |
| Spatially Resolved, Multi-Omics Analyses of Immune Infiltrates in GBM Microenvironment | NIH | National Cancer Institute | 2022 | $251,087 | September 16, 2022 | March 31, 2024 | GARBARINO, JENNIFER MARY | reporter.nih.gov |
| Microfluidics Platform for Spatial Multi-Omics Analysis of Tissue at Single Cell Resolution | NIH | National Human Genome Research Institute | 2022 | $221,977 | May 1, 2022 | October 31, 2022 | GENNARO, JOSEPH CHARLES | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|
| 2024 | 3 | $1,254,904 | 0 | $0 |
| 2023 | 1 | $1,390,826 | 0 | $0 |
| 2022 | 2 | $473,064 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|
| Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed) | PAR-25-255 | NIH | 93.172 | November 5, 2026 | Not listed | Same assistance listing 93.172 as 3 awards here |
| Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) | PAR-25-095 | NIH | 93.172 | November 6, 2026 | $350,000 | Same assistance listing 93.172 as 3 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.172 | November 16, 2026 | $50,000 | Same assistance listing 93.172 as 3 awards here |
| Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) | PAR-25-096 | NIH | 93.172 | November 17, 2026 | $200,000 | Same assistance listing 93.172 as 3 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.172 | November 18, 2026 | Not listed | Same assistance listing 93.172 as 3 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.172 | November 18, 2026 | Not listed | Same assistance listing 93.172 as 3 awards here |
| Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional) | PA-23-317 | NIH | 93.172 | November 24, 2026 | Not listed | Same assistance listing 93.172 as 3 awards here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Required) | PAR-24-295 | NIH | 93.172 | December 3, 2026 | Not listed | Same assistance listing 93.172 as 3 awards here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) | PAR-24-296 | NIH | 93.172 | December 3, 2026 | Not listed | Same assistance listing 93.172 as 3 awards here |
| NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) | RFA-OD-24-011 | NIH | 93.172 | December 4, 2026 | Not listed | Same assistance listing 93.172 as 3 awards here |
| Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed) | RFA-HG-27-007 | NIH | 93.172 | December 14, 2026 | $2 million | Same assistance listing 93.172 as 3 awards here |
| IGVF Data and Coordinating Center (U24 Clinical trials Not Allowed) | RFA-HG-27-008 | NIH | 93.172 | December 14, 2026 | $4 million | Same assistance listing 93.172 as 3 awards here |
| Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials Not Allowed) | RFA-HG-27-009 | NIH | 93.172 | December 14, 2026 | $1.5 million | Same assistance listing 93.172 as 3 awards here |
| Computational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, Clinical Trial Not Allowed) | RFA-HG-27-010 | NIH | 93.172 | December 14, 2026 | $800,000 | Same assistance listing 93.172 as 3 awards here |
| Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional) | PAR-27-039 | NIH | 93.172 | January 5, 2027 | Not listed | Same assistance listing 93.172 as 3 awards here |
| Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional) | PAR-27-040 | NIH | 93.172 | January 5, 2027 | Not listed | Same assistance listing 93.172 as 3 awards here |
| Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed) | PAR-25-256 | NIH | 93.172 | January 7, 2027 | Not listed | Same assistance listing 93.172 as 3 awards here |
| Genomic Community Resources (U24 Clinical Trials Not Allowed) | RFA-HG-26-002 | NIH | 93.172 | January 25, 2027 | Not listed | Same assistance listing 93.172 as 3 awards here |
| Research on the Ethical, Legal and Social Implications (ELSI) of Genomics | PAR-28-028 | NIH | 93.172 | February 16, 2027 | Not listed | Same assistance listing 93.172 as 3 awards here |
| Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional) | RFA-HG-25-009 | NIH | 93.172 | February 26, 2027 | Not listed | Same assistance listing 93.172 as 3 awards here |
Topics of its NIH awards
Updated November 4, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-04). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.